Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Bacteremia in Pediatric Cancer Patients : Causative Organisms and Antibiotic Sensitivities

소아 암 환자에서 발생한 균혈증 : 원인균과 항생제 감수성

  • Kim, Yong-Han (Department of Pediatrics, Yeungnam University College of Medicine) ;
  • Lee, Hyun-Dong (Department of Pediatrics, Yeungnam University College of Medicine) ;
  • Hah, Jeong-Ok (Department of Pediatrics, Yeungnam University College of Medicine)
  • 김용한 (영남대학교 의과대학 소아과학교실) ;
  • 이현동 (영남대학교 의과대학 소아과학교실) ;
  • 하정옥 (영남대학교 의과대학 소아과학교실)
  • Received : 2004.12.28
  • Accepted : 2005.03.17
  • Published : 2005.06.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Bacteremia in immunocompromised pediatric cancer patients can lead to high morbidity and mortality, if not treated early and properly. The incidence and antibiotic sensitivities to common pathogens of bacteremia in pediatric cancer patients are liable to change, according to region and time. We investigated the causative organisms and antibiotic sensitivities of bacteremia in pediatric cancer patients to assess the adequacy of empiric antimicrobial therapy. Methods : From September 1995 to August 2003, we retrospectively evaluated 58 episodes in 39 pediatric cancer patients with bacteremia treated at the Pediatric Department of Yeungnam University Hospital. We investigated and analyzed the causative organisms and the antibiotic sensitivity test results by reviewing the records of the microbiologically proven positive blood culture results. Results : The incidence of bacteremia in pediatric cancer patients in this study was 5.7 percent (58 episodes out of 1,022 occasions of blood cultures). Gram-positive organisms were isolated more often than gram-negative organisms (63.8 percent vs 36.2 percent) in the following order : Staphylococcus epidermidis (37.9 percent), Staphylococcus aureus (17.3 percent), Escherichia coli (12 percent), Streptococcus (8.6 percent), Enterobacter (6.9 percent), Klesiella (6.9 percent), Serratia (3.5 percent), Acinetobacter (3.5 percent), Proteus (1.7 percent) and Morganella morganii (1.7 percent). In antibiotic sensitivity tests, only six of 37 isolates (16 percent) of gram positive bacteria were sensitive to penicillin and 15 of 37 isolates (40 percent) were sensitive to oxacillin. All except one Staphylococcus aureus were sensitive to vancomycin and all except one Staphylococcus epidermidis were sensitive to teicoplanin among 37 isolates of gram positive bacteria. In the case of gram negative bacteria, two of 21 isolates (10 percent) and four of 21 isolates (19 percent) were sensitive to cefotaxime and ceftazidime, respectively. Only six of 21 isolates (29 percent) were sensitive to aminoglycoside, but all 21 isolates (100 percent) were sensitive to imipenem. All seven isolates tested after the year 2000 were sensitive to meropenem. Conclusion : In conclusion, we should choose the proper antimicrobials in treating pediatric cancer patients with suspected bacteremia, reflecting the increasing episodes of gram positive bacteremia and polymicrobial resistance of gram positive and negative organisms.

목 적 : 면역 저하된 소아 암 환자에서 균혈증은 조기에 적절한 치료를 하지 못하면 이환율과 사망률이 높아 질 수 있는 질환으로서 호발 원인균의 발생 빈도 및 항생제에 대한 감수성은 지역적 시기적으로 변화하는 경향이 있으므로 이를 조사하여 경험적 항생제 선택에 도움을 주고자 하였다. 방 법 : 1995년 9월부터 2003년 8월까지 영남대학교 의과대학부속병원 소아과에 입원한 소아 암 환자를 대상으로 병력지와 혈액배양검사 결과를 조사하여 균혈증이 확진된 39명, 58례를 대상으로 원인 균의 종류 및 항생제 감수성을 조사 분석하였다. 결 과 : 소아 암 환자에서 균혈증의 발생빈도는 균혈증이 의심되어 혈액배양을 시행한 1,022례 중 58례로 5.7%였다. 균혈증을 일으킨 가장 흔한 원인 균은 그람양성균으로 총 37례(63.8%) 였고 그람음성균은 총 21례(36.2%)였다. 그람양성균의 경우 Staphylococcus epidermidis (22례, 37.9%), Staphylococcus aureus (10례, 17.3%), Streptococcus (5례, 8.6%) 순이었고, 그람음성균의 경우 Escherichia coli (7례, 12%), Enterobacter (4례, 6.9%), Klebsiella (4례, 6.9%), Serratia (2례, 3.5%), Acinetobacter (2례, 3.5%), Proteus (1례, 1.7%), Morganella morganii (1례, 1.7%) 순으로 나타났다. 항생제 감수성 검사에서는 그람양성균 37례 중 6례(16%)에서만 penicillin 감수성을 나타내었고, 15례(40%)에서 oxacillin 감수성을 나타내었다. Staphylococcus aureus는 1례를 제외한 모든 예에서 vancomycin에, Staphylococcus epidermidis는 1례를 제외한 모든 예에서 teicoplanin에 감수성을 나타내었다. 그람음성균의 경우, 21례 중 2례(10%)만이 cefotaxime에, 4례(19%)에서만 ceftazidime에 감수성을 나타내었다. Aminoglycoside에는 21례 중 6례(29%) 에서만 감수성을 나타내었으며, 21례 모두에서 imipenem에 감수성을, 2000년 이후부터 감수성 검사를 시행한 meropenem에도 모든 예에서 감수성을 나타내었다. 결 론: 균혈증이 의심되는 소아 암 환자에서 그람양성균에 의한 균혈증이 증가하는 점과 그람양성균과 그람음성균 모두 항생제 다제내성 빈도가 증가하고 있음을 유념하여 적절한 항생제를 선택해야 할 것이다.

Keywords

References

  1. Korea National Statistical Office. Annual report on the cause of death statistics : based on vital registration. 2002:22-7
  2. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia : risks, consequences, and new directions for its management. Cancer 2004;100:228-37 https://doi.org/10.1002/cncr.11882
  3. Pizzo PA, Robichaud KJ, Wesley R, Commers JR. Fever in pediatric and young adult patient with cancer. Medicine 1982;61:153-65 https://doi.org/10.1146/annurev.med.042508.093728
  4. Roguin A, Kasis I, Ben-Arush MW, Sharon R, Berant M. Fever and neutropenia in children with malignant disease. Pediatr Hematol Oncol 1996;13:503-10 https://doi.org/10.3109/08880019609030865
  5. Lee SL, Kim JS, Kim HS, Kang JM. A study on infection in childhood acute leukemia. Korean J Infect Dis 1990;22: 33-41
  6. Rahiala J, Perkkiö M, Riikonen P. Infections occurring during the courses of anticancer chemotherapy in children with ALL : a retrospective analysis of 59 patients. Pediatr Hematol Oncol 1998;15:165-74 https://doi.org/10.3109/08880019809167231
  7. Lee JH, Kim KH, Seol IJ, Lee HJ, Lee H, Park CM. A clinical and laboratory study on infection in childhood leukemia. J Korean Pediatr Soc 1986;29:699-709
  8. Amman RA, Hirt A, Luthy AR, Aebi C. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J 2004;23:61-7 https://doi.org/10.1097/01.inf.0000106782.30100.4f
  9. Chanock SJ, Pizzo PA. Infectious complications of patients undergoing therapy for acute leukemia : current status and future prospects. Semin Oncol 1997;24:132-40
  10. Pizzo PA, Rubin M, Freifeld A, Walsh TJ. The child with cancer and infection. II. nonbacterial infections. J Pediatr 1991;119:845-57 https://doi.org/10.1016/S0022-3476(05)83032-X
  11. Paganini H, Bologna R, Debbag R, Casimir L, Gomez S, Rosanova M, et al. Fever and neutropenia in children with cancer in one pediatric hospital in Argentina. Pediatr Hematol Oncol 1998;15:405-13 https://doi.org/10.3109/08880019809016568
  12. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003;167:695-701 https://doi.org/10.1164/rccm.200207-682OC
  13. Auletta JJ, O'Riordan MA, Nieder ML. Infections in children with cancer : a continued need for the comprehensive physical examination. J Pediatr Hematol Oncol 1999;21:501-8. https://doi.org/10.1097/00043426-199911000-00011
  14. van de Wetering, Poole J, Freidland I, Caron HN. Bacteraemia in a paediatric oncology unit in South Africa. Med Pediatr Oncol 2001;37:525-31 https://doi.org/10.1002/mpo.1246
  15. Nachman JB, Honig GR. Fever and neutropenia in children with neoplastic disease. Cancer 1980;45:407-12 https://doi.org/10.1002/1097-0142(19800115)45:2<407::AID-CNCR2820450237>3.0.CO;2-S
  16. Pizzo PA, Rubin M, Freifeld A, Walsh TJ. The child with cancer and infection. I. empiric therapy for fever and neutropenia, and preventive strategies. J Pediatr 1991;119:679-94 https://doi.org/10.1016/S0022-3476(05)80281-1
  17. Gray JW, Pedler SJ, Craft AW, Kernahan J, Windebank KP, Pea AD. Changing causes of septicaemia in paediatric oncology patients : effect of imipenem use. Eur J Pediatr 1994;153:84-9 https://doi.org/10.1007/BF01959213
  18. Jones PD, Henry RL, Stuart J, Francis L. Suspected infection in children with cancer. J Qual Clin Pract 1998;18:275-84 https://doi.org/10.1046/j.1440-1762.1998.00284.x
  19. Viscoli C, Castagnola E, Giacchino M, Cesaro S, Properzi E, Tucci F, et al. Bloodstream infections in children with cancer : a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Eur J Cancer 1999;35:770-4. https://doi.org/10.1016/S0959-8049(99)00052-0
  20. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer : emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999;29:490-4 https://doi.org/10.1086/598620
  21. Shenep JL. Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents 2000;14:129-35 https://doi.org/10.1016/S0924-8579(99)00172-7
  22. Paya E, Alvarez AM, Aviles C, Cofre J, Enriquez N, Salgado C, et al. Causative agents of bloodstream infections in children with neoplasm, in 5 hospitals of Santiago (1994-1998). Rev Med Chil 2001;129:1297-304
  23. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003;36:1103-10 https://doi.org/10.1086/374339